Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 can cause various skin lesions, which may result from the virus and immune response, and are not directly linked to illness severity.

Hidradenitis suppurativa is caused by genetic factors, inflammation, bacteria, hormones, and lifestyle factors like obesity and smoking.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

Most hospitalized COVID-19 patients had long-term symptoms like fatigue and hair loss, with women and those sicker during hospitalization at higher risk.

Insulin resistance linked to obesity may increase COVID-19 severity.

COVID-19 may cause hair loss due to infection stress or treatments.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

Children generally have milder SARS symptoms than adults, with good outcomes and no deaths reported, but long-term effects are unclear.

Early detection and stopping the drug are key to managing DRESS, and careful monitoring is important due to possible severe reactions.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

COVID-19 can cause various skin problems, including reactions to protective gear and medication, with different rates reported worldwide, and more research is needed to fully understand these skin issues.

Imiquimod cream activates hair follicle stem cells and causes early hair growth by changing immune cells and certain protein expressions.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

Mesenchymal stromal cells may help treat severe COVID-19, but more research is needed to confirm their effectiveness.

COVID-19 may harm male fertility and damage the reproductive system.

Use PRP and ASC-BT for hair loss and wound healing, but more research needed.

The article suggests using safety measures and telemedicine for aesthetic dermatology during COVID-19, while some procedures can still be done safely.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

COVID-19 patients often have skin issues like chilblain-like lesions and rashes, which can help in early diagnosis and sometimes indicate severe illness.

Possible link between androgens and COVID-19 severity; more research needed.

COVID-19 patients may experience hair loss, but it's not linked to their age or sex.

H-1 antihistamines may help with various skin conditions, but more research is needed to confirm their effectiveness.

Some alopecia treatments might help treat COVID-19, but more research is needed.

Men, particularly those with hair loss, are more likely to get the virus, and those with prostate cancer may have milder symptoms. Testosterone's role in the disease is unclear, and the virus doesn't seem to harm male fertility. Women with PCOS might be at higher risk. More research is needed.

Skin problems are common after stem cell transplants, and early treatment by dermatologists can improve patient outcomes.

MSC-Exos can aid organ development and offer therapeutic benefits for various conditions.

COVID-19 changed dermatology by increasing telemedicine and highlighting healthcare disparities.